JP2011062204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011062204A5 JP2011062204A5 JP2010237516A JP2010237516A JP2011062204A5 JP 2011062204 A5 JP2011062204 A5 JP 2011062204A5 JP 2010237516 A JP2010237516 A JP 2010237516A JP 2010237516 A JP2010237516 A JP 2010237516A JP 2011062204 A5 JP2011062204 A5 JP 2011062204A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- nucleic acid
- atonal
- composition
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical group 0.000 claims 58
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 46
- 239000000203 mixture Substances 0.000 claims 35
- 125000003275 alpha amino acid group Chemical group 0.000 claims 24
- 241001465754 Metazoa Species 0.000 claims 22
- 210000004027 cell Anatomy 0.000 claims 14
- 239000003981 vehicle Substances 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 11
- 102000039446 nucleic acids Human genes 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 238000000034 method Methods 0.000 claims 8
- 239000013598 vector Substances 0.000 claims 8
- 108700028369 Alleles Proteins 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- 239000013603 viral vector Substances 0.000 claims 5
- 208000012659 Joint disease Diseases 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 231100000699 Bacterial toxin Toxicity 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 239000000688 bacterial toxin Substances 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 210000002768 hair cell Anatomy 0.000 claims 2
- 238000003780 insertion Methods 0.000 claims 2
- 230000037431 insertion Effects 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 210000002569 neuron Anatomy 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 239000013612 plasmid Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108020003175 receptors Proteins 0.000 claims 2
- 102000005962 receptors Human genes 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 241000700199 Cavia porcellus Species 0.000 claims 1
- 241000699800 Cricetinae Species 0.000 claims 1
- 241000252212 Danio rerio Species 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 208000016621 Hearing disease Diseases 0.000 claims 1
- 101000701142 Homo sapiens Transcription factor ATOH1 Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 241000255588 Tephritidae Species 0.000 claims 1
- 102100029373 Transcription factor ATOH1 Human genes 0.000 claims 1
- 210000004102 animal cell Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000006727 cell loss Effects 0.000 claims 1
- 230000007547 defect Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000003027 ear inner Anatomy 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000006870 function Effects 0.000 claims 1
- 208000016354 hearing loss disease Diseases 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 210000000412 mechanoreceptor Anatomy 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000001177 retroviral effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000026683 transduction Effects 0.000 claims 1
- 238000010361 transduction Methods 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13706099P | 1999-06-01 | 1999-06-01 | |
| US17699300P | 2000-01-19 | 2000-01-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500839A Division JP2003530817A (ja) | 1999-06-01 | 2000-06-01 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014048148A Division JP2014147387A (ja) | 1999-06-01 | 2014-03-11 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011062204A JP2011062204A (ja) | 2011-03-31 |
| JP2011062204A5 true JP2011062204A5 (enExample) | 2012-02-09 |
Family
ID=26834882
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500839A Pending JP2003530817A (ja) | 1999-06-01 | 2000-06-01 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
| JP2010237516A Pending JP2011062204A (ja) | 1999-06-01 | 2010-10-22 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
| JP2014048148A Pending JP2014147387A (ja) | 1999-06-01 | 2014-03-11 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
| JP2016106472A Pending JP2017006119A (ja) | 1999-06-01 | 2016-05-27 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001500839A Pending JP2003530817A (ja) | 1999-06-01 | 2000-06-01 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014048148A Pending JP2014147387A (ja) | 1999-06-01 | 2014-03-11 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
| JP2016106472A Pending JP2017006119A (ja) | 1999-06-01 | 2016-05-27 | 聴覚障害、変形性関節症および細胞の異常増殖に関するａｔｏｎａｌ関連配列の治療用途のための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6838444B1 (enExample) |
| EP (2) | EP2325198A1 (enExample) |
| JP (4) | JP2003530817A (enExample) |
| AT (1) | ATE490777T1 (enExample) |
| AU (1) | AU781802B2 (enExample) |
| CA (1) | CA2375106C (enExample) |
| CY (1) | CY1111499T1 (enExample) |
| DE (1) | DE60045350D1 (enExample) |
| DK (1) | DK1471926T3 (enExample) |
| PT (1) | PT1471926E (enExample) |
| WO (1) | WO2000073764A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053200B1 (en) * | 1999-06-01 | 2006-05-30 | Baylor College Of Medicine | Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation |
| US6821775B1 (en) * | 2000-02-11 | 2004-11-23 | Genvec, Inc. | Viral vector encoding pigment epithelium-derived factor |
| US20030224415A1 (en) * | 2001-06-29 | 2003-12-04 | Gala Design, Inc. | Selection free growth of host cells containing multiple integrating vectors |
| EP1337667A2 (en) * | 2000-11-16 | 2003-08-27 | Cedars-Sinai Medical Center | Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease |
| CA2513904A1 (en) * | 2003-01-21 | 2004-08-05 | Vib Vzw | Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| US20040166091A1 (en) * | 2003-02-24 | 2004-08-26 | Genvec, Inc. | Materials and methods for treating disorders of the ear |
| US8673634B2 (en) * | 2003-11-13 | 2014-03-18 | Massachusetts Eye & Ear Infirmary | Method for the treatment of hearing loss |
| US20050221429A1 (en) * | 2004-01-16 | 2005-10-06 | Cardinal Health Pts, Llc | Host cells containing multiple integrating vectors comprising an amplifiable marker |
| US8260401B2 (en) * | 2006-07-26 | 2012-09-04 | University Of Rochester | Non-invasive in-vivo imaging of mechanoreceptors in skin using confocal microscopy |
| WO2008076556A2 (en) | 2006-11-15 | 2008-06-26 | Massachusetts Eye & Ear Infirmary | Generation of inner ear cells |
| CA2714370C (en) | 2008-02-07 | 2017-05-02 | Massachusetts Eye & Ear Infirmary | Compounds that enhance atoh-1 expression |
| WO2012010675A2 (en) * | 2010-07-21 | 2012-01-26 | Universite Montpellier 2 Sciences Et Techniques | Bhlh proteins and their use as drugs |
| US9152861B2 (en) * | 2011-03-04 | 2015-10-06 | Nec Corporation | Individual product identification system, individual product identification method, and device and program used by same |
| CN102659951A (zh) * | 2012-05-29 | 2012-09-12 | 西安医学院 | 一种TAT结构域修饰的neurogenin2融合蛋白制备方法和用途 |
| CN104869987B (zh) | 2012-09-07 | 2020-10-16 | 麻省眼耳医院 | 用于再生毛细胞和/或支持细胞的方法及组合物 |
| CA2887642A1 (en) * | 2012-11-02 | 2014-05-08 | Genesys Research Institute | Compositions and methods for auditory therapy |
| WO2014145205A2 (en) | 2013-03-15 | 2014-09-18 | St. Jude Children's Research Hospital | Methods and compositions of p27kip1 transcription modulators |
| TWI710635B (zh) * | 2014-10-09 | 2020-11-21 | 美商珍維克公司 | 編碼人類無調同源物-1(hath1)之腺病毒載體 |
| WO2016069906A1 (en) | 2014-10-29 | 2016-05-06 | Massachusetts Eye And Ear Infirmary | Efficient delivery of therapeutic molecules to cells of the inner ear |
| EP3786164B1 (en) | 2015-06-18 | 2024-08-14 | Ting Therapeutics LLC | Methods and compositions for the prevention and treatment of hearing loss |
| US11111279B2 (en) | 2015-11-20 | 2021-09-07 | Grand Valley State University | Nato3 mutant polypeptides and uses thereof |
| US11331373B2 (en) | 2017-02-10 | 2022-05-17 | St. Jude Children's Research Hospital | Combination therapy for treating disorders of the ear |
| EP3743057A4 (en) | 2018-01-26 | 2021-11-17 | Massachusetts Eye & Ear Infirmary | TREATMENT OF HEARING LOSS |
| CN116178537B (zh) * | 2022-12-01 | 2024-10-29 | 福州迈新生物技术开发有限公司 | 抗Calretinin蛋白的单克隆抗体及其细胞株、制备方法和应用 |
| GB202407725D0 (en) | 2024-05-31 | 2024-07-17 | Mogrify Ltd | Cell conversion |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879236A (en) | 1984-05-16 | 1989-11-07 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
| US4957858A (en) | 1986-04-16 | 1990-09-18 | The Salk Instute For Biological Studies | Replicative RNA reporter systems |
| DE3785591T2 (de) | 1986-01-10 | 1993-09-02 | Amoco Corp | Kompetitiver homogener test. |
| EP0266032A1 (en) | 1986-08-29 | 1988-05-04 | Beecham Group Plc | Modified fibrinolytic enzyme |
| AU622104B2 (en) | 1987-03-11 | 1992-04-02 | Sangtec Molecular Diagnostics Ab | Method of assaying of nucleic acids, a reagent combination and kit therefore |
| IL86724A (en) | 1987-06-19 | 1995-01-24 | Siska Diagnostics Inc | Methods and kits for amplification and testing of nucleic acid sequences |
| AU622426B2 (en) | 1987-12-11 | 1992-04-09 | Abbott Laboratories | Assay using template-dependent nucleic acid probe reorganization |
| ATE92538T1 (de) | 1988-01-21 | 1993-08-15 | Genentech Inc | Verstaerkung und nachweis von nukleinsaeuresequenzen. |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| AU623642B2 (en) | 1988-03-24 | 1992-05-21 | University Of Iowa Research Foundation, The | Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved |
| US5932413A (en) | 1988-04-01 | 1999-08-03 | Celebuski; Joseph Eugene | DNA probe assay using neutrally charged probe strands |
| US5858652A (en) | 1988-08-30 | 1999-01-12 | Abbott Laboratories | Detection and amplification of target nucleic acid sequences |
| US4932207A (en) | 1988-12-28 | 1990-06-12 | Sundstrand Corporation | Segmented seal plate for a turbine engine |
| US5856092A (en) | 1989-02-13 | 1999-01-05 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
| US5925525A (en) | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
| US5849481A (en) | 1990-07-27 | 1998-12-15 | Chiron Corporation | Nucleic acid hybridization assays employing large comb-type branched polynucleotides |
| US5645987A (en) | 1990-09-21 | 1997-07-08 | Amgen Inc. | Enzymatic synthesis of oligonucleotides |
| US5846717A (en) | 1996-01-24 | 1998-12-08 | Third Wave Technologies, Inc. | Detection of nucleic acid sequences by invader-directed cleavage |
| US5849486A (en) | 1993-11-01 | 1998-12-15 | Nanogen, Inc. | Methods for hybridization analysis utilizing electrically controlled hybridization |
| US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
| EP0672181B1 (en) | 1992-04-01 | 2003-11-05 | The Johns Hopkins University School Of Medicine | Methods of detecting mammalian nucleic acids isolated from stool specimen and reagents therefor |
| US5792751A (en) | 1992-04-13 | 1998-08-11 | Baylor College Of Medicine | Tranformation of cells associated with fluid spaces |
| US5843640A (en) | 1992-06-19 | 1998-12-01 | Northwestern University | Method of simultaneously detecting amplified nucleic acid sequences and cellular antigens in cells |
| DE4228457A1 (de) | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
| US5861244A (en) | 1992-10-29 | 1999-01-19 | Profile Diagnostic Sciences, Inc. | Genetic sequence assay using DNA triple strand formation |
| US5707863A (en) | 1993-02-25 | 1998-01-13 | General Hospital Corporation | Tumor suppressor gene merlin |
| US5658751A (en) | 1993-04-13 | 1997-08-19 | Molecular Probes, Inc. | Substituted unsymmetrical cyanine dyes with selected permeability |
| GB9311386D0 (en) | 1993-06-02 | 1993-07-21 | Pna Diagnostics As | Nucleic acid analogue assay procedures |
| US5846709A (en) | 1993-06-15 | 1998-12-08 | Imclone Systems Incorporated | Chemical process for amplifying and detecting nucleic acid sequences |
| FR2708288B1 (fr) | 1993-07-26 | 1995-09-01 | Bio Merieux | Procédé d'amplification d'acides nucléiques par transcription utilisant le déplacement, réactifs et nécessaire pour la mise en Óoeuvre de ce procédé. |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| GB2284208A (en) | 1993-11-25 | 1995-05-31 | Pna Diagnostics As | Nucleic acid analogues with a chelating functionality for metal ions |
| EP0663447B1 (en) | 1993-12-28 | 2003-07-09 | Eiken Chemical Co., Ltd. | Method of detecting a specific polynucleotide |
| US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5851770A (en) | 1994-04-25 | 1998-12-22 | Variagenics, Inc. | Detection of mismatches by resolvase cleavage using a magnetic bead support |
| DE69527355T2 (de) | 1994-05-28 | 2003-03-06 | Tepnel Medical Ltd., Manchester | Herstellung von nukleinsaeurekopien |
| US5942391A (en) | 1994-06-22 | 1999-08-24 | Mount Sinai School Of Medicine | Nucleic acid amplification method: ramification-extension amplification method (RAM) |
| FR2722208B1 (fr) | 1994-07-05 | 1996-10-04 | Inst Nat Sante Rech Med | Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique |
| US5849483A (en) | 1994-07-28 | 1998-12-15 | Ig Laboratories, Inc. | High throughput screening method for sequences or genetic alterations in nucleic acids |
| JP3102800B2 (ja) | 1994-08-19 | 2000-10-23 | パーキン−エルマー コーポレイション | 増幅及び連結反応の共役法 |
| US5599668A (en) | 1994-09-22 | 1997-02-04 | Abbott Laboratories | Light scattering optical waveguide method for detecting specific binding events |
| US5871986A (en) | 1994-09-23 | 1999-02-16 | The General Hospital Corporation | Use of a baculovirus to express and exogenous gene in a mammalian cell |
| ATE340866T1 (de) | 1994-10-28 | 2006-10-15 | Gen Probe Inc | Zusammensetzungen und verfahren für die gleichzeitige detektion und quantifizierung von einer mehrheit spezifischer nuklein säure sequenzen |
| US5935825A (en) | 1994-11-18 | 1999-08-10 | Shimadzu Corporation | Process and reagent for amplifying nucleic acid sequences |
| US5866337A (en) | 1995-03-24 | 1999-02-02 | The Trustees Of Columbia University In The City Of New York | Method to detect mutations in a nucleic acid using a hybridization-ligation procedure |
| US5843650A (en) | 1995-05-01 | 1998-12-01 | Segev; David | Nucleic acid detection and amplification by chemical linkage of oligonucleotides |
| US5929227A (en) | 1995-07-12 | 1999-07-27 | The Regents Of The University Of California | Dimeric fluorescent energy transfer dyes comprising asymmetric cyanine azole-indolenine chromophores |
| US5916779A (en) | 1995-09-21 | 1999-06-29 | Becton, Dickinson And Company | Strand displacement amplification of RNA targets |
| US5866331A (en) | 1995-10-20 | 1999-02-02 | University Of Massachusetts | Single molecule detection by in situ hybridization |
| EP0866716A4 (en) | 1995-11-13 | 2002-05-02 | Cambridge Neuroscience Inc | METHOD FOR TREATING DISORDERS OF THE NON-VISUAL SENSORIC EPITHEL |
| US5612473A (en) | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
| US5851772A (en) | 1996-01-29 | 1998-12-22 | University Of Chicago | Microchip method for the enrichment of specific DNA sequences |
| US5837681A (en) | 1996-02-23 | 1998-11-17 | Amgen Inc. | Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product |
| US5929041A (en) | 1996-02-23 | 1999-07-27 | Amgen Inc. | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
| US5928906A (en) | 1996-05-09 | 1999-07-27 | Sequenom, Inc. | Process for direct sequencing during template amplification |
| US5912124A (en) | 1996-06-14 | 1999-06-15 | Sarnoff Corporation | Padlock probe detection |
| US5939291A (en) | 1996-06-14 | 1999-08-17 | Sarnoff Corporation | Microfluidic method for nucleic acid amplification |
| WO1998000014A1 (en) | 1996-06-28 | 1998-01-08 | The Regents Of The University Of California | Transformation and genetherapy of cells of the inner ear |
| US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| US5853990A (en) | 1996-07-26 | 1998-12-29 | Edward E. Winger | Real time homogeneous nucleotide assay |
| US5928870A (en) | 1997-06-16 | 1999-07-27 | Exact Laboratories, Inc. | Methods for the detection of loss of heterozygosity |
| US5849546A (en) | 1996-09-13 | 1998-12-15 | Epicentre Technologies Corporation | Methods for using mutant RNA polymerases with reduced discrimination between non-canonical and canonical nucleoside triphosphates |
| WO1998013048A1 (en) | 1996-09-27 | 1998-04-02 | Trustees Of The University Of Pennsylvania | Novel methods for inducing proliferation in auditory receptor epithelium |
| US5853992A (en) | 1996-10-04 | 1998-12-29 | The Regents Of The University Of California | Cyanine dyes with high-absorbance cross section as donor chromophores in energy transfer labels |
| US5853993A (en) | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| US6593290B1 (en) | 1996-11-01 | 2003-07-15 | Genentech, Inc. | Treatment of inner ear hair cells |
| US5900481A (en) | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
| US5905024A (en) | 1996-12-17 | 1999-05-18 | University Of Chicago | Method for performing site-specific affinity fractionation for use in DNA sequencing |
| US5846729A (en) | 1997-02-27 | 1998-12-08 | Lorne Park Research, Inc. | Assaying nucleotides in solution using a fluorescent intensity quenching effect |
| US5849497A (en) | 1997-04-03 | 1998-12-15 | The Research Foundation Of State University Of New York | Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker |
| US5846726A (en) | 1997-05-13 | 1998-12-08 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
| US5928869A (en) | 1997-05-30 | 1999-07-27 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
| US5919626A (en) | 1997-06-06 | 1999-07-06 | Orchid Bio Computer, Inc. | Attachment of unmodified nucleic acids to silanized solid phase surfaces |
| US6043221A (en) | 1997-07-30 | 2000-03-28 | Amgen Inc. | Method for preventing and treating hearing loss using a neuturin protein product |
| WO1999006034A1 (en) | 1997-08-01 | 1999-02-11 | Baylor College Of Medicine | Coup-tfi directed therapies in the treatment of disease |
| US5916776A (en) | 1997-08-27 | 1999-06-29 | Sarnoff Corporation | Amplification method for a polynucleotide |
| US5935791A (en) | 1997-09-23 | 1999-08-10 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
| US5932451A (en) | 1997-11-19 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Method for unbiased mRNA amplification |
| DE19807426A1 (de) | 1998-02-23 | 1999-10-14 | Otogene Biotechnologische Fors | Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs |
| AU1223500A (en) | 1998-10-21 | 2000-05-08 | Jonathan Kil | Methods for stimulating the regeneration of inner ear cells |
| KR100627754B1 (ko) | 1998-11-07 | 2006-09-26 | 제넨테크, 인크. | Ｈｅｒ2 및(또는) ｈｅｒ3 수용체에 대한 리간드를 이용한내이 모 세포 증식의 향상 방법 |
| US8312249B1 (en) | 2008-10-10 | 2012-11-13 | Apple Inc. | Dynamic trampoline and structured code generation in a signed code environment |
| FR2957821B1 (fr) | 2010-03-24 | 2014-08-29 | Inst Francais Du Petrole | Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives |
-
2000
- 2000-06-01 US US09/585,645 patent/US6838444B1/en not_active Expired - Lifetime
- 2000-06-01 JP JP2001500839A patent/JP2003530817A/ja active Pending
- 2000-06-01 AT AT00941220T patent/ATE490777T1/de active
- 2000-06-01 DE DE60045350T patent/DE60045350D1/de not_active Expired - Lifetime
- 2000-06-01 PT PT00941220T patent/PT1471926E/pt unknown
- 2000-06-01 EP EP10010154A patent/EP2325198A1/en not_active Withdrawn
- 2000-06-01 EP EP00941220A patent/EP1471926B8/en not_active Expired - Lifetime
- 2000-06-01 AU AU55959/00A patent/AU781802B2/en not_active Ceased
- 2000-06-01 DK DK00941220.6T patent/DK1471926T3/da active
- 2000-06-01 CA CA2375106A patent/CA2375106C/en not_active Expired - Lifetime
- 2000-06-01 WO PCT/US2000/015410 patent/WO2000073764A2/en not_active Ceased
-
2004
- 2004-06-03 US US10/860,373 patent/US7442688B2/en not_active Expired - Lifetime
- 2004-06-03 US US10/860,724 patent/US7470673B2/en not_active Expired - Lifetime
-
2010
- 2010-10-22 JP JP2010237516A patent/JP2011062204A/ja active Pending
-
2011
- 2011-02-28 CY CY20111100232T patent/CY1111499T1/el unknown
-
2014
- 2014-03-11 JP JP2014048148A patent/JP2014147387A/ja active Pending
-
2016
- 2016-05-27 JP JP2016106472A patent/JP2017006119A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011062204A5 (enExample) | ||
| JP2003530817A5 (enExample) | ||
| US20250262328A1 (en) | Gene Therapy for the Treatment of CNGB1-linked Retinitis Pigmentosa | |
| Pellissier et al. | Specific tools for targeting and expression in Müller glial cells | |
| WO2019183630A2 (en) | Gene editing for autosomal dominant diseases | |
| JP6023073B2 (ja) | ムコ多糖症におけるｃｎｓ病変を処置するための治療戦略 | |
| JP2018512125A (ja) | 多重ベクターシステム及びその使用 | |
| KR20170116055A (ko) | 최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도 | |
| WO2013063601A1 (en) | Chimeric promoter for cone photoreceptor targeted gene therapy | |
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| WO2017151717A1 (en) | Compositions and methods for adeno-associated virus mediated gene expression in myofibroblast-like cells | |
| JP2024505570A (ja) | 神経学的疾患及び疼痛を治療するためのエピジェネティック遺伝子調節 | |
| CN117813314A (zh) | 用于治疗神经纤维瘤疾患的组合物和方法 | |
| JP2023099082A (ja) | 筋強直性ジストロフィーの処置 | |
| TWI841566B (zh) | 用於治療黏多醣症 iv a 型之腺相關病毒載體 | |
| AU2019304569B2 (en) | Treatment of neuropathy with DNA constructs expressing IGF-1 isoforms | |
| JP7575273B2 (ja) | デュシェンヌ型筋ジストロフィーを治療するための組成物及び方法 | |
| US20230212275A1 (en) | Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration | |
| WO2019000093A1 (en) | PLATINUM TALE AND USE THEREOF TO INCREASE THE EXPRESSION OF FRATAXIN | |
| WO2024052413A1 (en) | Beta-hexosaminidase vectors | |
| CA3218631A1 (en) | Vector system | |
| KR20230112672A (ko) | 신경변성 질환을 위한 유전자 요법 | |
| US20210222139A1 (en) | Single adeno-associated virus (aav)-sized nucleotide for use in crispr interference or activation | |
| US20240342313A1 (en) | Vector encoding rod-derived cone viability factor and human igk signal sequence | |
| CN102355911A (zh) | 调节脂肪生成的Vgll3活性调节剂的用途 |